Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed COO

MyoKardia, Inc. (MYOK) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/27/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
11/27/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/24/2020 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
11/19/2020 4 Meeker David P (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 4,100 shares @ $0
Disposed/sold 22,000 options to buy @ $11.55, valued at $254.1k
Disposed/sold 11,000 options to buy @ $14, valued at $154k
Disposed/sold 11,000 options to buy @ $48.85, valued at $537.4k
Disposed/sold 6,600 options to buy @ $47.77, valued at $315.3k
Disposed/sold 3,000 options to buy @ $100.27, valued at $300.8k
11/19/2020 4 McDowell Robert Scott (Chief Scientific Officer) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 36,616 shares @ $0
Disposed/sold 87,074 options to buy @ $0.1838, valued at $16k
Disposed/sold 40,816 options to buy @ $0.3308, valued at $13.5k
Disposed/sold 36,735 options to buy @ $1.5068, valued at $55.4k
Disposed/sold 27,211 options to buy @ $9.08, valued at $247.1k
Disposed/sold 79,850 options to buy @ $12.25, valued at $978.2k
Disposed/sold 20,000 options to buy @ $13.9, valued at $278k
Disposed/sold 46,000 options to buy @ $52, valued at $2.4M
Disposed/sold 57,400 options to buy @ $40.11, valued at $2.3M
Disposed/sold 38,818 options to buy @ $70.4, valued at $2.7M
11/19/2020 4 Harris Taylor C. (CFO) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 42,559 shares @ $0
Disposed/sold 100,000 options to buy @ $48.5, valued at $4.9M
Disposed/sold 49,400 options to buy @ $40.11, valued at $2M
Disposed/sold 46,060 options to buy @ $70.4, valued at $3.2M
11/19/2020 4 AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 4,100 shares @ $0
Disposed/sold 22,000 options to buy @ $7.4, valued at $162.8k
Disposed/sold 11,000 options to buy @ $13.6, valued at $149.6k
Disposed/sold 11,000 options to buy @ $14, valued at $154k
Disposed/sold 11,000 options to buy @ $48.85, valued at $537.4k
Disposed/sold 6,600 options to buy @ $47.77, valued at $315.3k
Disposed/sold 3,000 options to buy @ $100.27, valued at $300.8k
11/19/2020 4 Fairey William (EVP, Chief Commercial Officer) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 42,199 shares @ $0
Disposed/sold 69,500 options to buy @ $40.99, valued at $2.8M
Disposed/sold 39,022 options to buy @ $70.4, valued at $2.7M
11/19/2020 4 Bauer Jake (Chief Business Officer) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 90,209 shares @ $0
Disposed/sold 16,530 options to buy @ $1.5068, valued at $24.9k
Disposed/sold 8,748 options to buy @ $9.08, valued at $79.4k
Disposed/sold 35,150 options to buy @ $12.25, valued at $430.6k
Disposed/sold 57,400 options to buy @ $40.11, valued at $2.3M
Disposed/sold 34,000 options to buy @ $52, valued at $1.8M
Disposed/sold 45,193 options to buy @ $70.4, valued at $3.2M
11/19/2020 4 PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 29,508 shares @ $0
Disposed/sold 21,800 options to buy @ $10, valued at $218k
Disposed/sold 11,000 options to buy @ $13.6, valued at $149.6k
Disposed/sold 11,000 options to buy @ $14, valued at $154k
Disposed/sold 11,000 options to buy @ $48.85, valued at $537.4k
Disposed/sold 6,600 options to buy @ $47.77, valued at $315.3k
Disposed/sold 3,000 options to buy @ $100.27, valued at $300.8k
11/19/2020 4 Popovits Kimberly J (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 4,100 shares @ $0
Disposed/sold 22,000 options to buy @ $14.35, valued at $315.7k
Disposed/sold 11,000 options to buy @ $14, valued at $154k
Disposed/sold 11,000 options to buy @ $48.85, valued at $537.4k
Disposed/sold 6,600 options to buy @ $47.77, valued at $315.3k
Disposed/sold 3,000 options to buy @ $100.27, valued at $300.8k
11/19/2020 4 CRANSTON MARY B (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 4,100 shares @ $0
Disposed/sold 11,000 options to buy @ $13.6, valued at $149.6k
Disposed/sold 11,000 options to buy @ $14, valued at $154k
Disposed/sold 11,000 options to buy @ $48.85, valued at $537.4k
Disposed/sold 6,600 options to buy @ $47.77, valued at $315.3k
Disposed/sold 3,000 options to buy @ $100.27, valued at $300.8k
11/19/2020 4 GIANAKAKOS ANASTASIOS (President and CEO) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 141,405 shares @ $0
Unknown transaction of 129,407 shares @ $0
Unknown transaction of 300,000 shares @ $0
Unknown transaction of 7,000 shares @ $0
Unknown transaction of 10,000 shares @ $0
Unknown transaction of 53,087 shares @ $0
Disposed/sold 149,517 options to buy @ $1.5068, valued at $225.3k
Disposed/sold 72,562 options to buy @ $9.08, valued at $658.9k
Disposed/sold 303,500 options to buy @ $12.25, valued at $3.7M
Disposed/sold 184,100 options to buy @ $52, valued at $9.6M
Disposed/sold 236,500 options to buy @ $40.11, valued at $9.5M
11/19/2020 4 YARNO WENDY L (Director) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 5,508 shares @ $0
Disposed/sold 22,000 options to buy @ $14.35, valued at $315.7k
Disposed/sold 11,000 options to buy @ $14, valued at $154k
Disposed/sold 11,000 options to buy @ $48.85, valued at $537.4k
Disposed/sold 6,600 options to buy @ $47.77, valued at $315.3k
Disposed/sold 3,000 options to buy @ $100.27, valued at $300.8k
11/19/2020 4 Waynick Denelle J (Chief Legal Officer) has filed a Form 4 on MyoKardia, Inc.
Txns: Unknown transaction of 25,000 shares @ $0
Disposed/sold 80,000 options to buy @ $93.84, valued at $7.5M
11/17/2020 8-K Resignation/termination of a director
Docs: "Amended and Restated Certificate of Incorporation of MyoKardia, Inc. (filed herewith)",
"Second Amended and Restated Bylaws of MyoKardia, Inc. (filed herewith)"
11/17/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/17/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/17/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/15/2020 GN MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten
11/13/2020 GN MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association's Scientific Sessions 2020
11/11/2020 GN MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy
11/10/2020 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 1.9% stake in MyoKardia Inc
11/10/2020 SC 13G/A FMR LLC reports a 0% stake in MYOKARDIA INC
11/10/2020 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a
11/05/2020 10-Q Quarterly Report for the period ended September 30, 2020
11/05/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/05/2020 8-K Quarterly results
Docs: "MyoKardia Reports Third Quarter 2020 Financial Results Acquisition of MyoKardia by Bristol-Myers Squibb Expected to Close During 4th Quarter of 2020"
11/05/2020 GN MyoKardia Reports Third Quarter 2020 Financial Results
11/04/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy